Eating disorder experts are concerned that the current focus on using diabetes drugs like Ozempic and Mounjaro off-label for weight loss may increase the risk of vulnerable individuals to develop eating disorders or make them worse. “My fear is that there is now a belief…

Read Full Article (External Site)